Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
deals
life sciences
national blog main
national top stories
roche
biopharma
cancer
cancer immunotherapy
center for medicare and medicaid services
companion diagnostic
daniel o'day
duchenne
europe blog main
europe top stories
fda
foundation medicine
foundationone cdx
foundationone heme
genentech
general assembly
health
healthcare
licensing
m&a
medicine
muscular dystrophy
new york blog main
osimertinib
podcasts
ro
rucaparib (rubraca)
san francisco blog main
sarepta therapeutics
tc
telehealth
What
billion
3
×
recently
3
×
medicine
roche
acquire
agreed
approval
betting
big
biopharma
bringing
broad
category
chief
confidence
date
deal
didn’t
digital
duchenne
episode
fda
focus
foundation
founder
gain
gene
genentech
growth
healthcare
highly
historic
major
million
momentum
morning
navigated
near
officer
operating
Language
unset
Current search:
billion
×
recently
×
@techcrunch.com
2 years ago
How one founder navigated a highly personal product category and a major shift in focus
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
